Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: J Cell Biochem. 2018 Sep 27;120(3):4321–4332. doi: 10.1002/jcb.27718

Figure 6: Comparisons of similarity of activated pathways among samples in normal controls (C1–5), CGD patients (D1–4) and of IFNGRD patients (N1–6).

Figure 6:

It was possible to detect that Cytoplasmatic Ribossomal proteins, mRNA processing, Type II Interferon signaling (IFNG), EGFR1 Signaling pathway, TGF-beta Receptor Signaling pathway and Insulin Signaling are present in different intensities in all samples.